- Home
- MIO vs OSUR Comparison
MIO vs OSUR Comparison
Compare MIO & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIO
- OSUR
- Stock Information
- Founded
- MIO 2021
- OSUR 2000
- Country
- MIO United States
- OSUR United States
- Employees
- MIO N/A
- OSUR N/A
- Industry
- MIO Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- MIO Finance
- OSUR Health Care
- Exchange
- MIO Nasdaq
- OSUR Nasdaq
- Market Cap
- MIO 200.3M
- OSUR 223.0M
- IPO Year
- MIO N/A
- OSUR 1986
- Fundamental
- Price
- MIO $11.75
- OSUR $3.10
- Analyst Decision
- MIO
- OSUR Hold
- Analyst Count
- MIO 0
- OSUR 1
- Target Price
- MIO N/A
- OSUR $3.00
- AVG Volume (30 Days)
- MIO 46.0K
- OSUR 750.0K
- Earning Date
- MIO 01-01-0001
- OSUR 08-05-2025
- Dividend Yield
- MIO 4.57%
- OSUR N/A
- EPS Growth
- MIO N/A
- OSUR N/A
- EPS
- MIO N/A
- OSUR N/A
- Revenue
- MIO N/A
- OSUR $161,626,000.00
- Revenue This Year
- MIO N/A
- OSUR N/A
- Revenue Next Year
- MIO N/A
- OSUR $6.20
- P/E Ratio
- MIO N/A
- OSUR N/A
- Revenue Growth
- MIO N/A
- OSUR N/A
- 52 Week Low
- MIO $9.18
- OSUR $2.36
- 52 Week High
- MIO $11.36
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- MIO 41.62
- OSUR 59.68
- Support Level
- MIO $11.78
- OSUR $3.00
- Resistance Level
- MIO $11.85
- OSUR $3.13
- Average True Range (ATR)
- MIO 0.07
- OSUR 0.12
- MACD
- MIO -0.01
- OSUR 0.00
- Stochastic Oscillator
- MIO 4.91
- OSUR 80.65
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.